transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65

/ 2020. The reason for the increase revenues due to increased sales of both domestic and international. Although it has the COVIC-19 epidemic situation, but still maintain a close relationship with

At the cabinet meeting on 10 March 2020, the cabinet approved several measures in the first-phase relief package to reduce both direct and indirect impact of the COVID-19 epidemic on the economy

million baht or 47.3 percent. Mainly due to the overall economic slowdown from the crisis situation from the epidemic of the Covid-19 virus, resulting in a reduced advertising expenditure in print media and

the Company having increased sales of products abroad. Despite the COVIC-19 epidemic situation, the company has maintained a close relationship with overseas customers through online systems. And the

indirect impact of the COVID-19 epidemic on the economy. In a move to restore capital market confidence, the cabinet approved an additional tax privilege for people who purchase investment units in “SSF

, which is increased from the same period of last year by 5 million baht or 510.20 percent. Although this year there has been the COVID-19 epidemic situation affecting all industries across the country and

% EBIT (27.73) (3.27) (24.46) 748.01% Net Profit (Loss) (21.72) (0.34) (21.38) 6288.24% Basic Earnings (Loss) per Share (0.110) (0.002) (0.108) 6288.24% Performance Report The epidemic of COVID-19 affects

1,901.2 1,664.5 1,112.0 236.7 14.2 789.2 71.0 Profit for the period 136.9 121.3 50.4 15.6 12.9 86.5 171.6 Thai Economy in Q2–2021 was visibly affected by the third round of the COVID-19 epidemic. As the

the following factors: 1) gradual relaxation of COVID-19 epidemic control measures and progress in vaccination 2) the impact of outstanding demand from the previous quarter and 3) government policies